Corrado Castellucci
Vorsitzender bei Recordati Orphan Drugs SAS
Aktive Positionen von Corrado Castellucci
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Recordati Rare Diseases UK Ltd.
Recordati Rare Diseases UK Ltd. Medical DistributorsDistribution Services Founded in 1996, Recordati Rare Diseases UK Ltd. is a pharmaceutical company that sells pharmaceutical products. The company is based in Maidenhead, UK and is part of CVC Advisers Ltd. | Direktor/Vorstandsmitglied | 07.05.2013 | - |
Recordati AG
Recordati AG Drugstore ChainsRetail Trade Recordati AG engages in the trading in as well as importation and exportation of pharmaceutical, biological, chemical, laboratory, and diagnostic products. It also provides consulting services in the areas of marketing and management, with focus on the pharmaceutical industry. The company was founded on June 8, 2011 and is headquartered in Baar, Switzerland. | Direktor/Vorstandsmitglied | - | - |
Recordati Orphan Drugs SAS
Recordati Orphan Drugs SAS Financial ConglomeratesFinance Part of CVC Capital Partners Plc, Recordati Orphan Drugs SAS is an investment holding French company. The company is based in Puteaux, France. The company was founded in 2007. Scott Lyons Pescatore has been the CEO of the company since 2020. | Vorsitzender | 12.06.2013 | - |
Karriereverlauf von Corrado Castellucci
Ehemalige bekannte Positionen von Corrado Castellucci
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Recordati Rare Diseases Germany GmbH
Recordati Rare Diseases Germany GmbH Medical DistributorsDistribution Services Recordati Rare Diseases Germany GmbH is a pharmaceutical wholesaler based in Germany. The German company's main focus is on distributing pharmaceutical products. | Vorstandsvorsitzender | - | - |
Adienne SRL
Adienne SRL Pharmaceuticals: MajorHealth Technology Adienne SRL manufactures pharmaceutical products. It offers drug products for oncohematology, autoimmune diseases, and bone marrow transplantation. The company was founded in 2004 and is headquartered in Caponago, Italy. | Vorstandsvorsitzender | 01.01.2010 | - |
AstraZeneca SpA
AstraZeneca SpA Pharmaceuticals: MajorHealth Technology AstraZeneca SpA engages in the production and distribution of pharmaceutical drugs and medicines. Its products specialize in the treatment and therapies for cardiovascular and metabolic, oncology, and respiratory inflammation, and autoimmunity diseases. The company was founded in April 1999 is headquartered in Basiglio, Italy. | Corporate Officer/Principal | 01.01.2004 | - |
Gilead Sciences Srl
Gilead Sciences Srl Pharmaceuticals: MajorHealth Technology Part of Gilead Sciences, Inc., Gilead Sciences Srl is a research-based biopharmaceutical company based in Milan, Italy. The Italian company's focus is on the discovery, development, and commercialization of innovative medicines. The company's pipeline includes investigational medicines with the potential to help advance care in HIV, viral hepatitis, cancer, and inflammation. | Vorstandsvorsitzender | 01.01.2007 | - |
RECORDATI | Corporate Officer/Principal | 01.04.2013 | - |
Statistik
International
Italien | 5 |
Deutschland | 2 |
Vereinigtes Königreich | 2 |
Operativ
Chief Executive Officer | 3 |
Corporate Officer/Principal | 2 |
Director/Board Member | 2 |
Sektoral
Health Technology | 5 |
Distribution Services | 3 |
Retail Trade | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
RECORDATI | Health Technology |
Private Unternehmen | 7 |
---|---|
AstraZeneca SpA
AstraZeneca SpA Pharmaceuticals: MajorHealth Technology AstraZeneca SpA engages in the production and distribution of pharmaceutical drugs and medicines. Its products specialize in the treatment and therapies for cardiovascular and metabolic, oncology, and respiratory inflammation, and autoimmunity diseases. The company was founded in April 1999 is headquartered in Basiglio, Italy. | Health Technology |
Gilead Sciences Srl
Gilead Sciences Srl Pharmaceuticals: MajorHealth Technology Part of Gilead Sciences, Inc., Gilead Sciences Srl is a research-based biopharmaceutical company based in Milan, Italy. The Italian company's focus is on the discovery, development, and commercialization of innovative medicines. The company's pipeline includes investigational medicines with the potential to help advance care in HIV, viral hepatitis, cancer, and inflammation. | Health Technology |
Adienne SRL
Adienne SRL Pharmaceuticals: MajorHealth Technology Adienne SRL manufactures pharmaceutical products. It offers drug products for oncohematology, autoimmune diseases, and bone marrow transplantation. The company was founded in 2004 and is headquartered in Caponago, Italy. | Health Technology |
Recordati Rare Diseases Germany GmbH
Recordati Rare Diseases Germany GmbH Medical DistributorsDistribution Services Recordati Rare Diseases Germany GmbH is a pharmaceutical wholesaler based in Germany. The German company's main focus is on distributing pharmaceutical products. | Distribution Services |
Recordati Rare Diseases UK Ltd.
Recordati Rare Diseases UK Ltd. Medical DistributorsDistribution Services Founded in 1996, Recordati Rare Diseases UK Ltd. is a pharmaceutical company that sells pharmaceutical products. The company is based in Maidenhead, UK and is part of CVC Advisers Ltd. | Distribution Services |
Recordati AG
Recordati AG Drugstore ChainsRetail Trade Recordati AG engages in the trading in as well as importation and exportation of pharmaceutical, biological, chemical, laboratory, and diagnostic products. It also provides consulting services in the areas of marketing and management, with focus on the pharmaceutical industry. The company was founded on June 8, 2011 and is headquartered in Baar, Switzerland. | Retail Trade |
Recordati Orphan Drugs SAS
Recordati Orphan Drugs SAS Financial ConglomeratesFinance Part of CVC Capital Partners Plc, Recordati Orphan Drugs SAS is an investment holding French company. The company is based in Puteaux, France. The company was founded in 2007. Scott Lyons Pescatore has been the CEO of the company since 2020. | Finance |
- Börse
- Insiders
- Corrado Castellucci
- Erfahrung